Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2014, Article ID 378048, 9 pages
http://dx.doi.org/10.1155/2014/378048
Review Article

Emerging Trends in Noninvasive Insulin Delivery

Department of Pharmacy, School of Medical & Allied Sciences, Galgotias University, Yamuna Expressway, Greater Noida, Uttar Pradesh, India

Received 2 January 2014; Revised 26 March 2014; Accepted 16 April 2014; Published 14 May 2014

Academic Editor: Praneet Opanasopit

Copyright © 2014 Arun Verma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Kurien, “Oral insulin Delivery-challenges and current status: a pharmaceutical review,” 2008, http://www.pharmainfo.net/pharma-student-magazine/oral-insulin-delivery-challenges-and-current-status.
  2. H. Richard and F. Denise, Biochemistry-Lippincott’s Illustrated Reviews, Lippincott Williams and Wilkins, 5th edition, 2012.
  3. M. D. Donovan, G. L. Flynn, and G. L. Amidon, “Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption,” Pharmaceutical Research, vol. 7, no. 8, pp. 863–868, 1990. View at Google Scholar · View at Scopus
  4. R. Hejazi and M. Amiji, “Chitosan-based gastrointestinal delivery systems,” Journal of Controlled Release, vol. 89, no. 2, pp. 151–165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Rinaudo, “Chitin and chitosan: properties and applications,” Progress in Polymer Science, vol. 31, no. 7, pp. 603–632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Felt, P. Buri, and R. Gurny, “Chitosan: a unique polysaccharide for drug delivery,” Drug Development and Industrial Pharmacy, vol. 24, no. 11, pp. 979–993, 1998. View at Google Scholar · View at Scopus
  7. S. A. Agnihotri, N. N. Mallikarjuna, and T. M. Aminabhavi, “Recent advances on chitosan-based micro- and nanoparticles in drug delivery,” Journal of Controlled Release, vol. 100, no. 1, pp. 5–28, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. V. R. Sinha, A. K. Singla, S. Wadhawan et al., “Chitosan microspheres as a potential carrier for drugs,” International Journal of Pharmaceutics, vol. 274, no. 1-2, pp. 1–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. K. Singla and M. Chawla, “Chitosan: some pharmaceutical and biological aspects—an update,” Journal of Pharmacy and Pharmacology, vol. 53, no. 8, pp. 1047–1067, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Issa, M. Köping-Höggård, and P. Artursson, “Chitosan and the mucosal delivery of biotechnology drugs,” Drug Discovery Today: Technologies, vol. 2, no. 1, pp. 1–6, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Kubota, N. Tatsumoto, T. Sano, and K. Toya, “A simple preparation of half N-acetylated chitosan highly soluble in water and aqueous organic solvents,” Carbohydrate Research, vol. 324, no. 4, pp. 268–274, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kofuji, C.-J. Qian, M. Nishimura, I. Sugiyama, Y. Murata, and S. Kawashima, “Relationship between physicochemical characteristics and functional properties of chitosan,” European Polymer Journal, vol. 41, no. 11, pp. 2784–2791, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Chatelet, O. Damour, and A. Domard, “Influence of the degree of acetylation on some biological properties of chitosan films,” Biomaterials, vol. 22, no. 3, pp. 261–268, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. W. W. Tin, W. C. Lai, B. K. Shyan, and P. W. S. Heng, “Aging and microwave effects on alginate/chitosan matrices,” Journal of Controlled Release, vol. 104, no. 3, pp. 461–475, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. T. W. Wong, “Use of microwave in processing of drug delivery systems,” Current Drug Delivery, vol. 5, no. 2, pp. 77–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. G. P. Carino and E. Mathiowitz, “Oral insulin delivery,” Advanced Drug Delivery Reviews, vol. 35, no. 2-3, pp. 249–257, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. Graves and G. S. Eisenbarth, “Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus,” Advanced Drug Delivery Reviews, vol. 35, no. 2-3, pp. 143–156, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Belchetz and P. Hammond, Color Atlas and Text of Diabetes and Endocrinology, Elsevier, Spain, 2004.
  19. WHO, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications, World Health Organization, Department of Non-Communicable Disease Surveillance, Geneva, Switzerland, 1999.
  20. N. A. Peppas and N. J. Kavimandan, “Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles,” European Journal of Pharmaceutical Sciences, vol. 29, no. 3-4, pp. 183–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. S. Mehanna, “Insulin and oral antidiabetic agents,” American Journal of Pharmaceutical Education, vol. 69, no. 5, article 89, 2005. View at Google Scholar · View at Scopus
  22. K. Chaturvedi, K. Ganguly, M. N. Nadagouda, and T. M. Aminabhavi, “Polymeric hydrogels for oral insulin delivery,” Journal of Controlled Release, vol. 165, pp. 129–138, 2013. View at Google Scholar
  23. T. Flood, “Advances in insulin delivery systems and devices: beyond the vial and syringe,” Insulin, vol. 1, no. 3, pp. 99–108, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Adams, N. Wang, and Y. Cui, “Future alternative therapies in a quest to halt aberrations in diabetes mellitus,” Biomedicine and Pharmacotherapy, vol. 59, no. 6, pp. 296–301, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. R. C. Mundargi, V. R. Babu, V. Rangaswamy, P. Patel, and T. M. Aminabhavi, “Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives,” Journal of Controlled Release, vol. 125, no. 3, pp. 193–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. V. R. Babu, P. Patel, R. C. Mundargi, V. Rangaswamy, and T. M. Aminabhavi, “Developments in polymeric devices for oral insulin delivery,” Expert Opinion on Drug Delivery, vol. 5, no. 4, pp. 403–415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, “Biodegradable polymeric nanoparticles as drug delivery devices,” Journal of Controlled Release, vol. 70, no. 1-2, pp. 1–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. P. F. Hite, A. M. Barnes, and P. E. Johnston, “Exhuberance over exubera,” Clinical Diabetes, vol. 24, no. 3, pp. 110–114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Aboubakar, H. Couvreur, G. Pinto-Alphandary, F. B. Lacour Bernard, F. Robert, and V. C. Puisieux, “Insulin-loaded nanocapsules for oral administration: in vitro and in vivo investigation,” Drug Development Research, vol. 49, pp. 109–117, 2000. View at Google Scholar
  30. A. K. Prusty and S. K. Sahu, “Development and evaluation of insulin incorporated nanoparticles for oral administration,” ISRN Nanotechnology, vol. 2013, Article ID 591751, 6 pages, 2013. View at Publisher · View at Google Scholar
  31. M. G. Von Herrath, T. Dyrberg, and M. B. A. Oldstone, “Oral insulin treatment suppresses virus-induced antigen-specific destruction of β cells and prevents autoimmune diabetes in transgenic mice,” Journal of Clinical Investigation, vol. 98, no. 6, pp. 1324–1331, 1996. View at Google Scholar · View at Scopus
  32. K. B. Choudhari, V. Labhasetwar, and A. K. Dorle, “Liposomes as a carrier for oral administration of insulin: effect of formulation factors,” Journal of Microencapsulation, vol. 11, no. 3, pp. 319–325, 1994. View at Google Scholar · View at Scopus
  33. H. Najafzadeh, H. Kooshapur, and F. Kianidehkordi, “Evaluation of an oral insulin formulation in normal and diabetic rats,” Indian Journal of Pharmacology, vol. 44, no. 1, pp. 103–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Elsayed, M. A. Remawi, N. Qinna, A. Farouk, and A. Badwan, “Formulation and characterization of an oily-based system for oral delivery of insulin,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 73, no. 2, pp. 269–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. C. Mundargi, V. Rangaswamy, and T. M. Aminabhavi, “Poly(N-vinylcaprolactam-co-methacrylic acid) hydrogel microparticles for oral insulin delivery,” Journal of Microencapsulation, vol. 28, no. 5, pp. 384–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. R. C. Mundargi, V. Rangaswamy, and T. M. Aminabhavi, “PH-Sensitive oral insulin delivery systems using Eudragit microspheres,” Drug Development and Industrial Pharmacy, vol. 37, no. 8, pp. 977–985, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. A. J. Hoogstraate and P. W. Wertz, “Drug delivery via the buccal mucosa,” Pharmaceutical Science and Technology Today, vol. 1, no. 7, pp. 309–316, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Veuillez, Y. N. Kalia, Y. Jacques, J. Deshusses, and P. Buri, “Factors and strategies for improving buccal absorption of peptides,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 51, no. 2, pp. 93–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Sudhakar, K. Kuotsu, and A. K. Bandyopadhyay, “Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs,” Journal of Controlled Release, vol. 114, no. 1, pp. 15–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. H. R. Costantino, L. Illum, G. Brandt, P. H. Johnson, and S. C. Quay, “Intranasal delivery: physicochemical and therapeutic aspects,” International Journal of Pharmaceutics, vol. 337, no. 1-2, pp. 1–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. M. I. Ugwoke, R. U. Agu, N. Verbeke, and R. Kinget, “Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives,” Advanced Drug Delivery Reviews, vol. 57, no. 11, pp. 1640–1665, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Arora, S. Sharma, and S. Garg, “Permeability issues in nasal drug delivery,” Drug Discovery Today, vol. 7, no. 18, pp. 967–975, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. W.-H. Shen and R.-J. Xu, “Gastrointestinal stability and absorption of insulin in suckling pigs,” Comparative Biochemistry and Physiology: A Molecular and Integrative Physiology, vol. 125, no. 3, pp. 389–401, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. P. C. Mills and S. E. Cross, “Transdermal drug delivery: basic principles for the veterinarian,” Veterinary Journal, vol. 172, no. 2, pp. 218–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. H. Krauland, D. Guggi, and A. Bernkop-Schnürch, “Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats,” Journal of Controlled Release, vol. 95, no. 3, pp. 547–555, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Tozaki, J. Komoike, C. Tada et al., “Chitosan Capsule for colon-specific drug delivery: improvement of insulin absorption from the rat colon,” Journal of Pharmaceutical Sciences, vol. 86, no. 9, pp. 1016–1021, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Bernkop-Schnürch, “Chitosan and its derivatives: potential excipients for peroral peptide delivery systems,” International Journal of Pharmaceutics, vol. 194, no. 1, pp. 1–13, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Veuillez, Y. N. Kalia, Y. Jacques, J. Deshusses, and P. Buri, “Factors and strategies for improving buccal absorption of peptides,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 51, no. 2, pp. 93–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. C. K. Oh and W. A. Ritschel, “Absorption characteristics of insulin through the buccal mucosa,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 12, no. 4, pp. 275–279, 1990. View at Google Scholar · View at Scopus
  50. B. Jeong, S. W. Kim, and Y. H. Bae, “Thermosensitive sol-gel reversible hydrogels,” Advanced Drug Delivery Reviews, vol. 54, no. 1, pp. 37–51, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. E. J. Ricci, L. O. Lunardi, D. M. A. Nanclares, and J. M. Marchetti, “Sustained release of lidocaine from Poloxamer 407 gels,” International Journal of Pharmaceutics, vol. 288, no. 2, pp. 235–244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Venugopalan, A. Sapre, N. Venkatesan, and S. P. Vyas, “Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization,” Pharmazie, vol. 56, no. 3, pp. 217–219, 2001. View at Google Scholar · View at Scopus
  53. Y. Luo, H. Xu, K. Huang, Z. Gao, H. Peng, and X. Sheng, “Study on a nanoparticle system for buccal delivery of insulin,” in Proceedings of the 27th IEEE Annual International Conference of the Engineering in Medicine and Biology Society (IEEE-EMBS '05), pp. 4842–4845, September 2005. View at Scopus
  54. E. A. Hosny, S. A. Elkheshen, and S. I. Saleh, “Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies,” Bollettino Chimico Farmaceutico, vol. 141, no. 3, pp. 210–217, 2002. View at Google Scholar · View at Scopus
  55. J. Sahni, S. Raj, F. Ahmad, and R. Khar, “Design and in-vitro characterization of buccoadhesive drug delivery system of insulin,” Indian Journal of Pharmaceutical Sciences, vol. 70, no. 1, pp. 61–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Portero, D. Teijeiro-Osorio, M. J. Alonso, and C. Remuñán-López, “Development of chitosan sponges for buccal administration of insulin,” Carbohydrate Polymers, vol. 68, no. 4, pp. 617–625, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. H.-B. Xu, K.-X. Huang, Y.-S. Zhu et al., “Hypoglycaemic effect of a novel insulin buccal formulation on rabbits,” Pharmacological Research, vol. 46, no. 5, pp. 459–467, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Modi, M. Mihic, and A. Lewin, “The evolving role of oral insulin in the treatment of diabetes using a novel RapidMist system,” Diabetes/Metabolism Research and Reviews, vol. 18, no. 1, pp. S38–S42, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. V. P. Guntur and R. Dhand, “Inhaled insulin: extending the horizons of inhalation therapy,” Respiratory Care, vol. 52, no. 7, pp. 911–922, 2007. View at Google Scholar · View at Scopus
  60. D. R. Bhumkar, H. M. Joshi, M. Sastry, and V. B. Pokharkar, “Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin,” Pharmaceutical Research, vol. 24, no. 8, pp. 1415–1426, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. A. B. Prasanth, V. Sankaranand, V. Venugopal et al., “Formulation and evaluation of bucco-adhesive tablets of insulin,” International Journal of Research in Pharmacy and Chemistry, vol. 1, pp. 172–178, 2011. View at Google Scholar
  62. B. W. Barry, “Novel mechanisms and devices to enable successful transdermal drug delivery,” European Journal of Pharmaceutical Sciences, vol. 14, no. 2, pp. 101–114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Chen, H. Zhu, J. Zheng et al., “Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin,” Journal of Controlled Release, vol. 139, no. 1, pp. 63–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. W. Chien, P. Lelawongs, O. Siddiqui, Y. Sun, and W. M. Shi, “Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices,” Journal of Controlled Release, vol. 13, no. 2-3, pp. 263–278, 1990. View at Google Scholar · View at Scopus
  65. W. Martanto, S. P. Davis, N. R. Holiday, J. Wang, H. S. Gill, and M. R. Prausnitz, “Transdermal delivery of insulin using microneedles in vivo,” Pharmaceutical Research, vol. 21, no. 6, pp. 947–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Malakar, S. O. Sen, A. K. Nayak, and K. K. Sen, “Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery,” Saudi Pharmaceutical Journal, vol. 20, no. 4, pp. 355–363, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. J. Guo, Q. Ping, and L. Zhang, “Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier,” Drug Delivery, vol. 7, no. 2, pp. 113–116, 2000. View at Google Scholar · View at Scopus
  68. E. J. Park, J. Werner, and N. B. Smith, “Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer,” Pharmaceutical Research, vol. 24, no. 7, pp. 1396–1401, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. M. J. Cano-Cebrián, T. Zornoza, L. Granero, and A. Polache, “Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery,” Current Drug Delivery, vol. 2, no. 1, pp. 9–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. B. L. Laube, “Treating diabetes with aerosolized insulin,” Chest, vol. 120, supplement 3, pp. 99S–106S, 2001. View at Google Scholar · View at Scopus
  71. Exubra(R) Package Insert, Pfizer Labs, New York, NY, USA, 2006.
  72. D. R. Owens, B. Zinman, and G. Bolli, “Alternative routes of insulin delivery,” Diabetic Medicine, vol. 20, no. 11, pp. 886–898, 2003. View at Publisher · View at Google Scholar · View at Scopus
  73. K. Rave, S. Bott, L. Heinemann et al., “Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin,” Diabetes Care, vol. 28, no. 5, pp. 1077–1082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. G. G. Briggs, Drugs in Pregnancy and Lactation Seventh Edition, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2005.
  75. W. T. Cefalu, J. S. Skyler, I. A. Kourides et al., “Inhaled human insulin treatment in patients with type 2 diabetes mellitus,” Annals of Internal Medicine, vol. 134, no. 3, pp. 203–207, 2001. View at Google Scholar · View at Scopus
  76. S. M. Setter, T. L. Levien, J. L. Iltz et al., “Inhaled dry powder insulin for the treatment of diabetes mellitus,” Clinical Therapeutics, vol. 29, no. 5, pp. 795–813, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Leal, R. N. Herrier, and M. Soto, “The role of rapid-acting insulin analogues and inhaled insulin in type 2 diabetes mellitus,” Insulin, vol. 2, no. 2, pp. 61–67, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. S. J. Skyler, P. A. Hollander, K. J. Lois, A. Sol, and R. J. Riese, “Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1diabetes: a 3- year randomize controlled trial,” Diabetes Research and Clinical Practice, vol. 82, no. 2, pp. 238–246, 2008. View at Google Scholar
  79. M. A. Reger, G. S. Watson, and S. Craft, “Intranasal insulin administration dose-dependently modulates verbal memory and plasma β-amyloid in memory- impaired older adults,” Journal of Alzheimer’s Disease, vol. 13, pp. 323–331, 2008. View at Google Scholar
  80. http://www.cadth.ca/en/products/environmental-scanning/issues-in-emerging-health-technologies/eh0003-inhaledinsulin.
  81. R. Kumria and G. Goomber, “Emerging trends in insulin delivery: buccal route,” Journal of Diabetology, vol. 2, pp. 1–9, 2011. View at Google Scholar
  82. P. C. Sharma, “A process for the preparation of oral insulin microcapsules,” Indian Patent 34/MAS/2002, 2002.
  83. B. Ecanow, “Oral insulin and a method of making same,” U.S. Patent 267749, 1990.
  84. B. A. Burnside, C. E. Mattes, C. M. M. C. Guinness, E. M. Rudnic, and G. W. Belendiuk, “Oral insulin delivery,” U.S. Patent 5824638, 1998.
  85. E. Arbit, R. Abbas, M. Goldberg, T. C. Woods, S. Dinn, and V. Wong, “Oral insulin therapy,” U.S. Patent 10500822, 2008.
  86. Y. Qian, L. J. Zhang, Z. M. Wu et al., “Enteric coated capsule containing cationic nanoparticles for oral insulin delivery,” U.S. Patent 20130034602, 2013.
  87. E. Arbit, M. Goldberg, and S. Majuru, “Oral insulin therapies and protocol,” U.S. Patent 20090253614, 2009.
  88. M. Gold Berg and E. Arbit, “Night time oral insulin therapy,” U.S. Patent 20060178296, 2006.
  89. V. Sabetsky, “Oral insulin composition and methods of making and using thereof,” U.S. Patent 20100166855, 2010.
  90. J. Zhang, “Biologically active oral preparation that can be site specific released in colon,” U.S. Patent 10297527, 2005.
  91. I. Gonda, R. M. Rubsamen, and S. J. Farr, “Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume,” U.S. Patent, 950562, 2004.
  92. I. Gonda, R. M. Rubsamen, and S. J. Farr, “Use of monomeric insulin as a means for improving bioavailability of inhaled insulin,” U.S. Patent 792616, 1999.
  93. S. S. Steiner and R. Pohl, “Rapid acting and prolonged acting inhaled insulin preparation,” U.S. Patent 20070086925, 2006.
  94. J. L. Schmitke, D. Chen, R. P. Batycky, D. A. Edwards, and J. Hrkach, “Particles for inhalation having rapid release properties,” U.S. Patent 20080227690, 2007.
  95. H. Brush, F.-N. Fu, M. M. Lipp, and J. L. Schmitke, “High load particles for inhalation having rapid release properties,” U.S. Patent 20070123449, 2006.
  96. K. G. E. Backstorm, C. M. O. Dahlback, P. Edman, and A. C. B. Johansson, “Therapeutic preparation for inhalation,” U.S. Patent 09/665585, 2003.
  97. J. S. Patton, L. Foster, and R. M. Platz, “Method and composition for pulmonary delivery of insulin,” U.S. Patent 821493, 1999.
  98. I. Gonda and R. M. Rubsamen, “Method of delivering insulin lispro,” U.S. Patent 069721, 1999.
  99. K. G. E. Backstorm, C. M. O. Dahlback, P. Edman, and A. C. B. Johansson, “Process for preparing composition for inhalation,” U.S. Patent 858122, 1999.
  100. I. Gonda, R. M. Rubsamen, and S. J. Farr, “Method of treating a diabetic patient by aerosolized administration of insulin,” U.S. Patent 088534, 2000.
  101. P. Modi, “Pharmaceutical composition for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least 3 micelle—forming compounds,” U.S. Patent 574504, 2002.
  102. P. Modi, “Method for administering insulin to the buccal region,” U.S. Patent 09538829, 2006.